G2GBio

456160· KOSDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

₩36,650+19.58%

2026-08-04

Financials

Valuation Metrics

G2GBio's Market Cap is ₩6095B. At end of 2025 it was ₩1.1T. Ranked #391 of 2,436 in KR market (top 16%), #128 of 1,649 on KOSDAQ (top 8%), #43 of 234 in Pharmaceuticals, Biotechnology & Life Sciences (top 18%) by Market Cap.

Investment Metrics(as of 2026-08-04)

Metric	Value	Rank
Size
Market Cap	609.47B KRW	KR#391/2,436 Sec#43/234
Revenue	766.0M KRW	KR#2,393/2,436 Sec#220/234
Net Income	-14.73B KRW	KR—/2,436 Sec—/234
Total Assets	236.90B KRW	KR#1,159/2,436 Sec#81/234
Net Assets	144.34B KRW	KR#1,132/2,436 Sec#83/234
Value
P/B	4.22x	KR#2,209/2,436 Sec#182/234
P/S	795.61x	KR#2,409/2,436 Sec#224/234
FCF Yield	-2.34%	KR—/2,436 Sec—/234
Profitability
ROE	-10.20%	KR#1,901/2,436 Sec#147/234
ROA	-6.22%	KR#1,950/2,436 Sec#148/234
Op. Margin	-1650.52%	KR#2,394/2,436 Sec#221/234
Revenue Growth	4364.31%	KR#1/2,436 Sec#1/234
Financial Health
Debt Ratio	164.13%	KR#1,367/2,436 Sec#156/234
Total Debt	39.09B KRW	KR#1,084/2,436 Sec#79/234
FCF	-14.23B KRW	KR#1,814/2,436 Sec#165/234
Cash	24.82B KRW	KR#1,113/2,436 Sec#76/234
Current Ratio	2.48x	KR#759/2,436 Sec#94/234
Performance
1M Return	-1.61%	KR#1,055/2,436 Sec#101/234
From 52W High	-70.44%	KR#2,151/2,436 Sec#197/234
1Y MDD	-80.68%	KR#2,309/2,436 Sec#216/234
Trading
Volume	327,758 shares	KR#373/2,436 Sec#40/234
Foreign Own.	9.22%	KR#512/2,436 Sec#42/234
Per Share
EPS	-961 KRW	KR—/2,436 Sec—/234
BPS	8,313 KRW	KR#1,055/2,436 Sec#73/234